PYC
PYC Therapeutics Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
PYC Therapeutics Ltd. is a drug-development company, which offers a new generation of RNA therapeutics to meet unmet need in disease. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2005-03-30. The firm has RNA targeted therapeutics design capabilities to deliver technologies based on cell penetrating peptides (CPPs) and peptide conjugated phosphorodiamidate morpholino oligomer (PPMOs). The firm develops a pipeline of therapies, including two programs, which are focused on inherited eye diseases and preclinical discovery programs, which are focused on neurodegenerative and kidney diseases. The Company’s lead drug candidate, VP-001 is designed to treat Retinitis pigmentosa 11 (RP11). The second lead drug candidate PYC-001, which is focused on treating autosomal dominant optic atrophy (ADOA). Its preclinical, clinical, regulatory and corporate operations are based in San Diego, California. The firm's discovery and laboratory operations are located in Australia.
📈 Performance
Price History
+44.97%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.06
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PYC
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in PYC
N/A
PYC investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in PYC also invest in...
DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.
📊 Share price
$7.69 AUD
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
📊 Share price
$12.45 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL EX AUSTRALIA
TECH.AX was created on 2017-04-06 by Global X. The fund's investment portfolio concentrates primarily on information technology equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Morningstar Developed Markets Technology Moat Focus IndexSM (the Index).
📊 Share price
$90.86 AUD
NULL GLOBAL
NULL SMART BETA
NULL THEMATIC
ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)
📊 Share price
$74.40 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
Want more shares? Try these...
Payright Ltd. engages in the provision of payment plan services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-23. The firm provides point of sale consumer finance solutions. The principal activity of the Company and its subsidiaries is to provide merchants with flexible lending finance solutions to offer their customers, intended for higher value transactions that are more considered purchases rather than smaller impulse-driven buys. The firm practices lending and performs identification and credit checks to ensure a customer’s repayment capability. Merchants are paid upfront and in full on the same day and include a diverse mix of broad-reaching products and services, such as direct sales businesses, home improvement, education, photography, dental, and health and beauty. The firm provides services to customers and merchants in Australia and New Zealand.
📊 Share price
$0.01 AUD
Qualitas Ltd. engages in real estate management services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-12-16. The firm is focused on private credit and equity across commercial real estate sectors. The firm operates through two segments: Funds Management and Direct Lending. The Funds Management segment includes all of its core funds management activities and includes funds management fees, performance fees and other fee income. The company also includes dividends and distributions from its co-investment and direct lending activities. The Direct Lending segment relates to the interest income and expenses relating to activities undertaken by the Company's wholly owned subsidiaries, Arch Finance and Peer Estate. Arch Finance is a non-bank commercial real estate mortgage originator and lender. The company has access to diversified investment opportunities across commercial real estate markets, capital structures, fund types, and real estate sub-asset classes.
📊 Share price
$2.64 AUD
PolarX Ltd. is a mineral exploration and development company, which focuses on gold and copper exploration and its development. The company is headquartered in Subiaco, Western Australia and currently employs 1 full-time employees. The company went IPO on 2012-12-21. The firm is focused on copper, gold, and silver projects in United States of America. Its projects include Caribou Dome Copper project, Stellar Copper-Gold project, Humboldt Range Gold-Silver project, and Fourth of July project. The Caribou Dome Copper project comprises approximately 216 contiguous state mining claims and is located adjacent to the Company’s Stellar project. The claims cover a total area of 116 square kilometers (km2). The Stellar Copper-Gold project comprises approximately 231 contiguous State Mining Claims and is located immediately adjacent to the Company’s Caribou Dome Copper Project. The claims cover a total area of 150 Km2. The Humboldt Range Gold-Silver project comprises 364 lode mining claims in Nevada in two claim groups: Black Canyon and Fourth of July and is situated between two large-scale active mines: the Florida Canyon gold mine and the Rochester silver-gold mine.
📊 Share price
